The role of lncRNAKCNQ1OT1/miR-301b/Tcf7 axis in cardiac hypertrophy
Cardiology in the Young · 2024
DOI: 10.1017/s1047951124000155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology in the Young, 2024. Verfasst von Mingyao E und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Baicheng Medical College, Baicheng, China. Hauptthemen laut MEDLINE: MicroRNAs, Cardiomegaly, RNA, Long Noncoding. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objective
Cardiac hypertrophy, acting as a pathologic process of chronic hypertension and coronary disease, and its underlying mechanisms still need to be explored. Long non-coding RNA (LncRNA) potassium voltage-gated channel subfamily Q member 1 Transcript 1 (KCNQ1OT1) has been implicated in myocardial infarction. However, its role in cardiac hypertrophy remains reported.
Method
To explore the regulated effect of lncRNAKCNQ1OT1 and miR-301b in cardiac hypertrophy, gain-and-lose function assays were tested. The expression of lncRNAKCNQ1OT1 and miR-301b were tested by quantitative real time polymerase chain reaction (qRT-PCR). The levels of transcription factor 7 (Tcf7), Proto-oncogene c-myc (c-myc), Brainnatriureticpeptide (BNP) and β-myosin heavy chain (β-MHC) were detected by Western blot. Additionally, luciferase analysis revealed interaction between lncRNAKCNQ1OT1, BNPβ-MHCmiR-301b, and Tcf7.
Result
LncRNAKCNQ1OT1 overexpression significantly induced cardiac hypertrophy. Furthermore, lncRNAKCNQ1OT1 acts as a sponge for microRNA-301b, which exhibited lower expression in cardiac hypertrophy model, indicating an anti-hypertrophic role. Furthermore, the BNP and β-MHC expression increased, as well as cardiomyocyte surface area, with Ang II treatment, while the effect was repealed by miR-301b. Moreover, the protein expression of Tcf7 was inversely regulated by miR-301b and Antisense miRNA oligonucleotides (AMO)-301b.
Conclusion
Our study has shown that overexpression of lncRNAKCNQ1OT1 could promote the development of cardiac hypertrophy by regulating miR-301b and Tcf7. Therefore, inhibition of lncRNAKCNQ1OT1 might be a potential therapeutic strategy for cardiac hypertrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Baicheng Medical College, Baicheng, China.
- Nursing Department of Baicheng Hospital, Baicheng Medical College, Baicheng, China.
ORCID-Profile: Mingyao E
Zitieren
APA
E, M., Ren, F., Yu, Y., Li, H., & Shen, C. (2024). The role of lncRNAKCNQ1OT1/miR-301b/Tcf7 axis in cardiac hypertrophy. Cardiology in the Young. https://doi.org/10.1017/s1047951124000155
Vancouver
E M, Ren F, Yu Y, Li H, Shen C. The role of lncRNAKCNQ1OT1/miR-301b/Tcf7 axis in cardiac hypertrophy. Cardiology in the Young. 2024. doi:10.1017/s1047951124000155
BibTeX
@article{E2024,
author = {E, Mingyao and Ren, Feifei and Yu, Yanhua and Li, Haiyan and Shen, Chao},
title = {The role of lncRNAKCNQ1OT1/miR-301b/Tcf7 axis in cardiac hypertrophy},
journal = {Cardiology in the Young},
year = {2024},
doi = {10.1017/s1047951124000155}
}
EUVIMED